Previous issue | Volume 84 | ESPE2015 | Next issue

54th Annual ESPE

Barcelona, Spain
01 Oct 2015 - 03 Oct 2015

Card image cap
Barcelona, Spain; 1-3 October 2015 Further information

Working Groups

Diabetes Technology and Therapeutics Thursday, 1 October

New Technologies in Treating Patients with Type 2 Diabetes
aArea of Endocrinology and Diabetes, University Campus Bio-Medico of Rome, Rome, Italy; bCentre of Diabetes, St. Bartholomew’s and The London School of Medicine, Queen Mary University of London, London, UK
hrp0084wg2.1
The Pros and Cons of Using Sulfonylurea before Genetic Testing in Neonatal Diabetes Mellitus
IMAGINE Institute, Hôpital Necker Enfants Malades, Université Paris Descartes, Paris, France
hrp0084wg2.2
Are Genetic Tests Necessary before Starting the Treatment of a Patient with Neonatal Diabetes? CON
aSchneider Children’s Medical Center of Israel, Petah Tikva, Israel; bSackler Faculty of Medicine, Tel-Aviv, Israel
hrp0084wg2.3
Blood Glucose Monitoring: Which is Better: Continuous Real-Time or Episodic Real-Time on Demand? PRO
Schneider Children’s Medical Center of Israel, Petah Tikva, Israel
hrp0084wg2.4
Type 2 Diabetes Mellitus in Adolescence
Vestische Children’s Hospital, University of Witten/Herdecke, Datteln, Germany
hrp0084wg2.6
The Rationale and Potential Role of Surgery in the Treatment of Adolescent Diabetes
Cincinnati Children’s Hospital Medical Center, Cincinnati, Ohio, USA
hrp0084wg2.7